Skip to content

A Prospective, Pilot Evaluation of Device Equivalence

Validation of MolecuLight Phoenix Prototypes in Clinic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03754426
Acronym
Equivalence
Enrollment
50
Registered
2018-11-27
Start date
2018-11-26
Completion date
2019-01-02
Last updated
2019-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound

Brief summary

Patients with chronic wounds will be imaged using 3 imaging devices. Two types of images will be acquired with each device, as standard photograph (ST-image) and a fluorescence image (FL-image). The images captured with the 3 imaging devices will be compared off-line by 5 interpreters to assess for any differences in the images that would alter a clinical decision.

Detailed description

Patients (n = 50) with chronic wounds will be imaged using 3 imaging devices. Two types of images will be acquired with each device, as standard photograph (ST-image) and a fluorescence image (FL-image). The images captured with the 3 imaging devices will be compared off-line by 5 interpreters to assess for any differences in the images that would alter a clinical decision.

Interventions

DEVICEFluorescence Imaging Device

Hand-held, real-time fluorescence imaging device

Sponsors

MolecuLight Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects (inpatient/outpatient) presenting with a wound * Wound size less than 15 cm in length * 18 years or older

Exclusion criteria

* Treatment with an investigational drug within 1 month before study enrolment * Subjects with recent (\<30 days) biopsy or curettage of target wound * Subjects with wounds that cannot be completely imaged by study device due to anatomic location * Unable or unwilling to consent

Design outcomes

Primary

MeasureTime frameDescription
Concordance2 monthsEstimate concordance of moderate/heavy bacterial load present in images acquired with each of 3 devices

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026